REPLIGEN CORP·4

Jul 17, 4:40 PM ET

Garland Jason K 4

Research Summary

AI-generated summary

Updated

Repligen CFO Jason Garland Sells 530 Shares

What Happened
Jason K. Garland, Chief Financial Officer of Repligen Corp (RGEN), sold 530 shares of company stock on July 16, 2026, at $150.00 per share, for a total proceeds of $79,500. This was a sale (disposition), not a purchase.

Key Details

  • Transaction date and price: July 16, 2026 — 530 shares at $150.00 each.
  • Total value: $79,500.
  • Shares owned after transaction: Not specified in this Form 4 filing.
  • Footnote: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.
  • Filing/timeliness: Form filed July 17, 2026 (timely relative to the reported transaction).

Context
Sales executed under a 10b5-1 plan are pre-arranged trades and are generally treated as routine rather than a direct signal of the insider’s current view. For retail investors, purchases often carry more informational weight than small open-market sales; this transaction represents a modest $79.5k disposition by the CFO.